RAB10 and Parkinson disease: Compared with healthy controls, neutrophils of mutation carriers with PD robustly displayed a higher fraction of phosphorylated Rab10, namely a 2.2-fold increase in pRab10 levels (p-value <0.05) (Fig. 4K).